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Congenital and heterosexual syphilis: Still part of the problem
Elizabeth A. Torrone, PhD, MSPH1, William C. Miller, MD, PhD, MPH2
1.Division of STD Prevention, Division of STD Prevention
2.College of Public Health, The Ohio State University
Short summary:
Although the U.S. syphilis epidemic is concentrated among men who have sex with men, the 
number of congenital syphilis cases and the primary and secondary syphilis rate among women 
both doubled in recent years.
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In the United States (U.S.), diagnoses of syphilis fell dramatically after the introduction of 
penicillin, but concurrent with the sexual revolution, began increasing during the 1960s. 
Cases continued to rise, hitting a peak in 1990 with over 135,000 cases reported.(1,2) At the 
time, syphilis appeared to be less common among gay, bisexual and other men who have sex 
with men (collectively referred to as MSM), perhaps due to changes in sexual behavior 
related to the AIDS epidemic,(3) and was primarily reported among heterosexuals, likely 
tied to the crack cocaine epidemic.(4,5) Following intensive public health interventions, 
including targeted screening and intensive partner services, syphilis rates fell and by the late 
1990s, syphilis was nearing elimination in the U.S.(6) In 2000, fewer than 6,000 cases of 
primary and secondary (P&S) syphilis were reported, down from 50,000 cases in 1990. 
Cases of congenital syphilis, syphilitic infection in a newborn, had decreased from over 
4,400 cases in 1991 to fewer than 600 cases in 1999. Before elimination could be declared, 
cases of P&S syphilis began climbing again, doubling to over 15,000 cases in 2012. But this 
time, the epidemic appeared to be primarily among MSM. Congenital syphilis cases 
remained low, reaching a nadir of 334 cases in 2012. Then in 2013, the epidemic shifted 
slightly and concurrent with continued increases among MSM, syphilis increased among 
both women and newborns. During 2012–2016, the number congenital syphilis cases (334 to 
628 cases) and the P&S syphilis rate among women (0.9 to 1.9 cases per 100,000 females) 
both doubled. (1)
The current U.S. syphilis epidemic remains concentrated among MSM with 58% of P&S 
syphilis cases occurring among MSM in 2016;(1) however, rising rates among females and 
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the increased number of congenital syphilis cases is a growing public health concern. Like 
other bacterial sexually transmitted infections, syphilis in adults can be prevented by 
consistent use of condoms and/or mutual monogamy with a negative partner. Although early 
signs and symptoms of syphilis in women (e.g., a vaginal or oral chancre) can be missed or 
mistaken for another infection (e.g., herpes), syphilis among women can be diagnosed with a 
simple blood test and can be cured with antibiotics. However, if undiagnosed and untreated, 
syphilis can facilitate HIV acquisition (7) and, although rare, can lead to severe 
complications, such as ocular syphilis and neurosyphilis. (8) Syphilitic infection in pregnant 
women has even more severe consequences, including miscarriage and stillbirth, and infants 
born with a syphilitic infection can suffer from bone deformities, jaundice, and neurological 
problems including blindness and deafness.(8) Congenital syphilis is preventable by 1) 
preventing women with syphilis from getting pregnant, 2) preventing pregnant women from 
getting syphilis, and 3) identifying and treating pregnant women with syphilis prior (>30 
days) to delivery. Additionally, the long-term consequences of congenital syphilis can be 
minimized by ensuring that infants exposed to syphilis are treated appropriately. Congenital 
syphilis is completely avoidable. Therefore, a case of congenital syphilis represents a failure 
of the health care system and should be considered a sentinel event. As congenital syphilis 
requires an infection in a pregnant woman, heterosexual and congenital syphilis are 
inextricably linked providing multiple opportunities for prevention and control.
This section of the current issue focuses on heterosexual and congenital syphilis in the U.S. 
Kidd and colleagues provide an in-depth review of recent trends in congenital syphilis and 
present a novel congenital syphilis prevention cascade, estimating the proportion of potential 
congenital syphilis cases averted, and identifying opportunities for intervention.(10) Plotzker 
and colleagues conduct a review of current interventions to prevent congenital syphilis, 
highlighting both evidence-based interventions, such as routine screening during pregnancy, 
as well as promising strategies, such as using point-of care syphilis tests in settings that 
might reach women of reproductive age who are not linked to prenatal care.(11) Finally, 
Berruti and colleagues investigate the cost-effectiveness of antenatal syphilis screening using 
a decision tree model to estimate costs and outcomes of timing of antenatal screening.(12) 
Although these manuscripts will help inform and refine prevention and control of congenital 
syphilis in the U.S., it is also critical to consider what might have caused the epidemic to 
shift back to the heterosexual population after nearing elimination in the 1990s and to 
identify key areas for future research.
In the 36 states that reliably reported sex of sex partner data for P&S syphilis cases during 
2012–2016, 31% of all P&S cases were reported among women and men who have sex with 
women only (MSW) in 2016, a 17% increase from the proportion of cases that were among 
heterosexuals in 2012. (1) This increased proportion of heterosexual cases reflects an 
increasing number of cases diagnosed among both MSW (99% increase during 2012–2016; 
1,616 to 3,211 cases) and women (112% increase; 1,216 to 2,579 cases). The number of 
cases among MSM showed a slower increase (64% increase; 7,728 to 12,654 cases). These 
changes in the syphilis epidemic may be a result of several intertwined factors, including 
failure to control the epidemic in MSM, changes in sexual networks, and changes in health 
care access.
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One hypothesis for the increasing rates among heterosexual populations is increased mixing 
between sexual networks, with an increased number of men who have sex with both men 
and women (MSMW) serving as “bridges” between MSM and heterosexual networks. In a 
recent analysis of over 40,000 HIV nucleotide sequences from 25 jurisdictions, HIV 
infection among heterosexual women likely originated from both heterosexual men (about 
21% of linked pairs) and MSM (about 29% of linked pairs) in potential transmission pairs 
(i.e., those with close genetic distance), with the remainder of women linked to heterosexual 
females (likely representing an indirect connection to a man) and persons who inject drugs.
(13) This finding suggests that bridging between MSM and heterosexual networks may play 
an important role in HIV transmission dynamics in the U.S. Syphilis transmission dynamics 
differ from HIV, as sexual transmission of syphilis requires exposure to a mucosal or 
cutaneous syphilitic lesion, which are self-limiting (e.g., a few weeks or months).(14) 
Additionally, lesions may occur in the rectum of MSM, limiting the potential to expose 
female partners. Consequently, more frequent mixing may be required to transmit syphilis 
across MSM and heterosexual networks. But bridging may have contributed to the recent 
shift in the syphilis epidemic, similar to the HIV patterns. Given the large increase in the 
number of MSM with syphilis (64% increase in the last 5 years), the number of MSM who 
also have sex with women who have acquired syphilis has likely increased (even if the 
overall proportion that are MSMW in the population has stayed stable), increasing the 
probably of bridging between sexual networks. The delayed increase in the heterosexual 
population may be attributable, at least in part, to the short window of infectiousness of 
syphilis and the proportionately small number of MSMW in the population. These factors 
would limit bridging events. Nonetheless, these explanations are hypothetical—the 
frequency of bridging events and the resulting impact on observed syphilis rates are 
unknown. Understanding the role of bridging in the current syphilis epidemic could inform 
allocation of prevention resources. For example, will it be possible to control the growing 
heterosexual epidemic using prevention strategies from the 1990s (e.g., partner services, 
screening), or will it be necessary to control syphilis among MSM to control syphilis among 
heterosexual populations?
Increases in syphilis among heterosexuals may also be independent of increases among 
MSM. In the concurrent crack cocaine and syphilis epidemics in the 1990s, drug use and 
sexual transmitted infections (STIs) were intimately intertwined. The use of prescription 
pain relievers, heroin, other opioids, and methamphetamine has increased nationwide (15) 
and may be contributing to current syphilis rates. Drug use can be linked to often coercive 
sexual behaviors associated with STIs, such as trading sex for drugs/money, survival sex, 
and sex trafficking. Drug use can also result in poverty, homelessness, and reduced access to 
health care, all of which can affect the risk of acquiring syphilis. Persons actively using 
illegal drugs may be hesitant to seek medical care, even when they have symptoms of 
syphilis; as a result, their duration of infection is longer, increasing the probability of 
transmitting the infection to their partners. Pregnant women who are using drugs may also 
delay seeking health care, as some states consider substance use during pregnancy to be 
considered child abuse.(16) For pregnant women with syphilis, this delay may lead to 
continued transmission to sexual partners and increase the risk of congenital syphilis. The 
impact of the current opioid crisis on STIs, including syphilis, in rural areas of the U.S. is 
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the focus of eight ongoing cooperative agreements with support from the National Institute 
of Drug Abuse, the Centers for Disease Control and Prevention (CDC), Substance Abuse 
and Mental Health Services Administration, and the Appalachian Regional Commission.(17)
Understanding factors, such as risk behaviors, associated with the current syphilis epidemic 
is critical to identifying intervention opportunities; however, it is difficult to monitor trends 
in reported behaviors among persons diagnosed with syphilis. Behavioral information, such 
as sex of sex partners, may not be systematically captured in medical records and is often 
missing on provider case report forms. Although many syphilis cases are interviewed by 
public health staff for partner services, providing an opportunity to capture patient-reported 
behaviors, social desirability bias may limit accurate disclosure. Consequently, some men 
reported as heterosexual may be men who have sex with men. If over time men became less 
likely to disclose that they have had sex with men, heterosexual rates could increase 
independent of changes in morbidity. Similarly, more complete disclosure of behaviors over 
time could distort trends. As efforts to control the opioid epidemic in the U.S. grow, it is 
likely that more healthcare providers and public health staff will discuss substance use with 
patients resulting in more complete information on drug-related behaviors in syphilis case 
reports. Consequently, trends in reported drug abuse could increase independent of changes 
in actual drug use. It is important to consider the inherent limitations of surveillance data 
when using case report data to identify intervention opportunities.
Increases in rates of syphilis among women have been noted in all regions of the U.S. in 
recent years. In 2016, at least one case of congenital syphilis was reported in 37 states and 
Washington DC.(1) But the epidemics of heterosexual and congenital syphilis remain 
concentrated. In 2016, 47% of all P&S syphilis cases among women and 61% of all 
congenital syphilis cases were reported from four states (California, Florida, Louisiana, and 
Texas). Understanding local drivers of the syphilis epidemic in these high prevalence areas is 
key to controlling national rates. Recently the CDC awarded funding to nine jurisdictions 
with high rates of congenital syphilis. These supplemental funds will be used to bolster local 
congenital syphilis control and prevention efforts, including using local congenital syphilis 
case review boards to identify root causes of congenital syphilis in the jurisdiction and to 
identify opportunities for individual- or systems-level strengthening to prevent future cases.
(18)
The surge in syphilis observed among MSM has recently been paired with corresponding 
increases in syphilis among women and consequently, congenital syphilis. The underlying 
factors contributing to the heterosexual syphilis and congenital syphilis cases are unclear, but 
bridging from the MSM epidemic and substance use may play a role. More distal factors, 
such as poverty and access to quality healthcare, as well as social vulnerabilities, such as 
incarceration and homelessness, are additional contributors (19, 20). Stemming the current 
epidemic will require a multi-level approach, combining individual-level interventions, such 
as ensuring all pregnant women are screened for syphilis during the first prenatal care visit, 
as well as interventions that address underlying socioeconomic factors. (21) Regardless, one 
thing is clear—congenital syphilis is entirely preventable and its control should be a high 
priority for sexually transmitted disease prevention efforts.
Torrone and Miller Page 4
Sex Transm Dis. Author manuscript; available in PMC 2019 December 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
References
1. CDC. Sexually Transmitted Disease Surveillance 2016. Atlanta, GA: U.S. Department of Health and 
Human Services; 2017.
2. Aral SO, Fenton KA, Holmes KK. Sexually transmitted diseases in the USA: temporal trends. Sex 
Transm Infect. 2007 Jul;83(4):257–66.
3. Chesson HW, Dee TS, Aral SO. AIDS mortality may have contributed to the decline in syphilis rates 
in the United States in the 1990s. Sexually transmitted diseases. 2003;30(5):419–24. [PubMed: 
12916133] 
4. Finelli L, Budd J, Spitalny KC. Early syphilis. Relationship to sex, drugs, and changes in high-risk 
behavior from 1987–1990. Sexually transmitted diseases. 1993;20(2):89–95. [PubMed: 8503065] 
5. Rolfs RT, Goldberg M, Sharrar RG. Risk factors for syphilis: cocaine use and prostitution. American 
journal of public health. 1990;80(7):853–7. [PubMed: 2356911] 
6. CDC. The national plan to eliminate syphilis from the United States. U.S. Department of Health and 
Human Services; 1999 Available at: https://www.cdc.gov/stopsyphilis/Plan.pdf (Accessed October 
9, 2017)
7. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the 
contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually 
transmitted infections. 1999;75(1):3–17. [PubMed: 10448335] 
8. Ghanem KG. REVIEW: Neurosyphilis: A historical perspective and review. CNS neuroscience & 
therapeutics. 2010;16(5):e157–68. [PubMed: 20626434] 
9. Shafii TRJ, Sánchez PJ, et al. Congenital syphilis In: Holmes KK SP, Stamm WE, et al., editor. 
Sexually Transmitted Diseases, 4th Edition New York, NY2008 p. 1577–612.
10. Kidd S, Bowen VB, Torrone EA, Bolan G. Use of National Syphilis Surveillance Data to Develop 
a Congenital Syphilis Prevention Cascade and Estimate the Number of Potential Congenital 
Syphilis Cases Averted. Sexually Transmitted Disease. 2017 [will be updated once special issue 
issue publication date is determined]
11. Plotzker R, Murphy R, Stotley. Congenital Syphilis: Strategies, Evidence, and Future Drecionts. 
Sexually Transmitted Disease. 2017 [will be updated once special issue issue publication date is 
determined]
12. Berruti A, Gift T. Cost-effectiveness of antenatal screening for congenital syphilis in the U.S. 
Sexually Transmitted Disease. 2017 [will be updated once special issue issue publication date is 
determined]
13. Oster AM, Wertheim JO, Hernandez AL, et al. Using Molecular HIV Surveillance Data to 
Understand Transmission Between Subpopulations in the United States. Journal of acquired 
immune deficiency syndromes. 2015;70(4):444–51. [PubMed: 26302431] 
14. Sparling PF, Swartz MN, Musher DM, et al. Clinical Manifestations of Syphilis In: Holmes KK, 
Sparling PF, Stamm WE, Piot P, Wasserheti JN, Corey L, Cohen MS, Watts DH, eds. Sexually 
Transmitted Diseases. 4th ed. New York, NY: McGraw Hill; 2008: 661–684.
15. Carlisle Maxwell J The Pain Reliever and Heroin Epidemic in the United States: Shifting Winds in 
the Perfect Storm. J Addict Dis. 2015;34(2–3):127–40. [PubMed: 26106929] 
16. ACOG. Substance Abuse Reporting and Pregnancy: The Role of the Obstetrician-Gynecologist. 
Committee on Health Care for Underserved Women 2011 Available at: https://www.acog.org/
Resources-And-Publications/Committee-Opinions/Committee-on-Health-Care-for-Underserved-
Women/Substance-Abuse-Reporting-and-Pregnancy-The-Role-of-the-Obstetrician-Gynecologist 
(Accessed October 9, 2017)
17. Grants awarded to address opioid crisis in rural regions [press release]. 2017 Available at: https://
www.hhs.gov/hepatitis/blog/2017/09/06/grants-awarded-to-address-opioid-crisis-in-rural-
regions.html (Accessed October 9, 2017)
18. STD AAPPS Supplemental Funding for Enhanced Congenital Syphilis Response. Centers for 
Disease Control and Prevention; 2017.
19. DiOrio D, Kroeger K, Ross A. Social Vulnerability in Congenital Syphilis Case Mothers: 
Qualitative Assessment of Cases in Indiana, 2014–2016 Sexually Transmitted Diseases: 1 4, 2018 
- Volume Publish Ahead of Print - Issue - doi: 10.1097/OLQ.0000000000000783
Torrone and Miller Page 5
Sex Transm Dis. Author manuscript; available in PMC 2019 December 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
20. Hogben M, Leichliter JS. Social determinants and sexually transmitted disease disparities. Sex 
Transm Dis. 2008 12;35(12 Suppl):S13–8. doi: 10.1097/OLQ.0b013e31818d3cad. Review. 
[PubMed: 18936725] 
21. Frieden TR. A framework for public health action: the health impact pyramid. Am J Public Health. 
2010 4;100(4):590–5. doi: 10.2105/AJPH.2009.185652. Epub 2010 Feb 18. [PubMed: 20167880] 
Torrone and Miller Page 6
Sex Transm Dis. Author manuscript; available in PMC 2019 December 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
